Positive News SentimentPositive NewsNASDAQ:NATR Nature's Sunshine Products (NATR) Stock Price, News & Analysis → “The Stock Market’s Bull Run is Far from Over” -Barrons (From Vertical Research Advisory) (Ad) Free NATR Stock Alerts $20.77 +0.54 (+2.67%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$20.37▼$21.0550-Day Range$17.16▼$20.7752-Week Range$9.86▼$21.72Volume87,481 shsAverage Volume52,511 shsMarket Capitalization$390.89 millionP/E Ratio26.97Dividend YieldN/APrice Target$24.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Nature's Sunshine Products alerts: Email Address Nature's Sunshine Products MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside15.6% Upside$24.00 Price TargetShort InterestHealthy0.66% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.02 out of 5 starsMedical Sector616th out of 938 stocksPharmaceutical Preparations Industry279th out of 422 stocks 2.5 Analyst's Opinion Consensus RatingNature's Sunshine Products has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $24.00, Nature's Sunshine Products has a forecasted upside of 15.6% from its current price of $20.77.Amount of Analyst CoverageNature's Sunshine Products has only been the subject of 1 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.66% of the float of Nature's Sunshine Products has been sold short.Short Interest Ratio / Days to CoverNature's Sunshine Products has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nature's Sunshine Products has recently increased by 13.00%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldNature's Sunshine Products does not currently pay a dividend.Dividend GrowthNature's Sunshine Products does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NATR. Previous Next 3.3 News and Social Media Coverage News SentimentNature's Sunshine Products has a news sentiment score of 1.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Nature's Sunshine Products this week, compared to 1 article on an average week.Search Interest7 people have searched for NATR on MarketBeat in the last 30 days. This is an increase of 250% compared to the previous 30 days.MarketBeat FollowsOnly 6 people have added Nature's Sunshine Products to their MarketBeat watchlist in the last 30 days. This is a decrease of -25% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Nature's Sunshine Products insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.70% of the stock of Nature's Sunshine Products is held by insiders.Percentage Held by Institutions79.40% of the stock of Nature's Sunshine Products is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Nature's Sunshine Products is 26.97, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 147.65.Price to Earnings Ratio vs. SectorThe P/E ratio of Nature's Sunshine Products is 26.97, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 276.03.Price to Book Value per Share RatioNature's Sunshine Products has a P/B Ratio of 2.48. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Vertical Research Advisory“The Stock Market’s Bull Run is Far from Over” -BarronsBarron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months!Click here for all the details now… About Nature's Sunshine Products Stock (NASDAQ:NATR)Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. Nature's Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.Read More NATR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NATR Stock News HeadlinesMarch 15, 2024 | finance.yahoo.comNature's Sunshine Products, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their PredictionsMarch 14, 2024 | marketwatch.comNature's Sunshine Shares Touch 52-Week High After 4Q UpdateMarch 28, 2024 | Vertical Research Advisory (Ad)“The Stock Market’s Bull Run is Far from Over” -BarronsBarron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months!March 13, 2024 | finance.yahoo.comWhy Nature's Sunshine (NATR) Stock Is Up TodayMarch 13, 2024 | finanznachrichten.deNature's Sunshine Products, Inc.: Nature's Sunshine Reports Strong Fourth Quarter and Full Year 2023 Financial ResultsMarch 12, 2024 | finance.yahoo.comNature's Sunshine (NASDAQ:NATR) Misses Q4 Sales TargetsMarch 12, 2024 | gurufocus.comNature's Sunshine Products Inc (NATR) Reports Significant Growth in Q4 and Full Year 2023 EarningsMarch 12, 2024 | globenewswire.comNature's Sunshine Reports Strong Fourth Quarter and Full Year 2023 Financial ResultsMarch 28, 2024 | Vertical Research Advisory (Ad)“The Stock Market’s Bull Run is Far from Over” -BarronsBarron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months!March 11, 2024 | benzinga.comPreview: Natures Sunshine Products's EarningsMarch 11, 2024 | finance.yahoo.comNature's Sunshine (NATR) Q4 Earnings: What To ExpectFebruary 20, 2024 | finance.yahoo.comNature’s Sunshine Sets Fourth Quarter and Full Year 2023 Conference Call for Tuesday, March 12, 2024, at 5:00 p.m. ETFebruary 20, 2024 | globenewswire.comNature's Sunshine Sets Fourth Quarter and Full Year 2023 Conference Call for Tuesday, March 12, 2024, at 5:00 p.m. ETFebruary 6, 2024 | finance.yahoo.comIs There Now An Opportunity In Nature's Sunshine Products, Inc. (NASDAQ:NATR)?January 31, 2024 | seekingalpha.comNature's Sunshine Products: Unconvincing Trajectory Despite ImprovementsJanuary 2, 2024 | finance.yahoo.comNature’s Sunshine Announces Participation at the 26th Annual Needham Growth Conference on January 19, 2024December 21, 2023 | finance.yahoo.comNature's Sunshine Products, Inc. (NASDAQ:NATR) is definitely on the radar of institutional investors who own 39% of the companyDecember 19, 2023 | finance.yahoo.comNature’s Sunshine Recognized with Best Company Culture AwardDecember 12, 2023 | benzinga.comNatures Sunshine Products Stock (NASDAQ:NATR), Quotes and News SummaryNovember 27, 2023 | msn.comNature`s Sunshine Products (NATR) Price Target Increased by 10.26% to 21.93November 23, 2023 | finance.yahoo.comThe Return Trends At Nature's Sunshine Products (NASDAQ:NATR) Look PromisingNovember 9, 2023 | finance.yahoo.comInvesting in Nature's Sunshine Products (NASDAQ:NATR) a year ago would have delivered you a 108% gainNovember 8, 2023 | morningstar.comNatures Sunshine Products Inc NATRNovember 8, 2023 | finance.yahoo.comNature’s Sunshine Products, Inc. (NASDAQ:NATR) Q3 2023 Earnings Call TranscriptNovember 7, 2023 | finance.yahoo.comNature's Sunshine Reports Strong Third Quarter 2023 ResultsOctober 24, 2023 | finance.yahoo.comNature’s Sunshine Sets Third Quarter 2023 Conference Call for Tuesday, November 7, 2023, at 5:00 p.m. ETSeptember 20, 2023 | finance.yahoo.comNature’s Sunshine Names Sarah Crockett Global Chief Marketing OfficerSee More Headlines Receive NATR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nature's Sunshine Products and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/07/2018Today3/28/2024Next Earnings (Estimated)5/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPersonal Products Current SymbolNASDAQ:NATR CUSIP63902710 CIK275053 Webwww.naturessunshine.com Phone(801) 341-7900Fax801-342-4305Employees814Year FoundedN/APrice Target and Rating Average Stock Price Target$24.00 High Stock Price Target$24.00 Low Stock Price Target$24.00 Potential Upside/Downside+15.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)$0.77 Trailing P/E Ratio26.97 Forward P/E RatioN/A P/E GrowthN/ANet Income$15.08 million Net Margins3.39% Pretax Margin4.54% Return on Equity12.25% Return on Assets7.75% Debt Debt-to-Equity RatioN/A Current Ratio2.16 Quick Ratio1.29 Sales & Book Value Annual Sales$445.32 million Price / Sales0.88 Cash Flow$1.65 per share Price / Cash Flow12.60 Book Value$8.36 per share Price / Book2.48Miscellaneous Outstanding Shares18,820,000Free Float17,935,000Market Cap$390.89 million OptionableOptionable Beta0.81 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Terrence O. Moorehead (Age 60)President, CEO & Director Comp: $762.12kMr. L. Shane Jones (Age 53)Executive VP, CFO & Treasurer Mr. Martin Gonzalez (Age 55)Executive Vice President of Global Supply Chain Operations Comp: $546.38kTrent McCauslandExecutive Director, Head of Operations & COOMr. Nathan G. Brower (Age 44)Executive VP, General Counsel & Secretary Ms. Sarah CrockettGlobal Chief Marketing OfficerMs. Tracee Comstock (Age 58)Vice President of Human Resources Mr. Bryant J. Yates (Age 51)Executive VP & President of Europe Comp: $496.15kMr. Daniel C. Norman (Age 50)Executive VP & President of Asia/Pacific (APAC) Comp: $574.31kMr. Kevin R. HerbertExecutive VP & President of North AmericaMore ExecutivesKey CompetitorsCorbus PharmaceuticalsNASDAQ:CRBPInozyme PharmaNASDAQ:INZYMereo BioPharma GroupNASDAQ:MREOAnnexonNASDAQ:ANNXESSA PharmaNASDAQ:EPIXView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Bought 14,722 shares on 3/11/2024Ownership: 3.439%Goldman Sachs Group Inc.Sold 29,615 shares on 3/1/2024Ownership: 0.053%Public Employees Retirement System of OhioBought 4,051 shares on 2/16/2024Ownership: 0.050%Occudo Quantitative Strategies LPBought 1,040 shares on 2/15/2024Ownership: 0.059%Citadel Advisors LLCBought 1,800 shares on 2/15/2024Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions NATR Stock Analysis - Frequently Asked Questions Should I buy or sell Nature's Sunshine Products stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nature's Sunshine Products in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" NATR shares. View NATR analyst ratings or view top-rated stocks. What is Nature's Sunshine Products' stock price target for 2024? 1 Wall Street research analysts have issued 12-month target prices for Nature's Sunshine Products' stock. Their NATR share price targets range from $24.00 to $24.00. On average, they expect the company's share price to reach $24.00 in the next year. This suggests a possible upside of 15.6% from the stock's current price. View analysts price targets for NATR or view top-rated stocks among Wall Street analysts. How have NATR shares performed in 2024? Nature's Sunshine Products' stock was trading at $17.29 at the start of the year. Since then, NATR shares have increased by 20.1% and is now trading at $20.77. View the best growth stocks for 2024 here. When is Nature's Sunshine Products' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our NATR earnings forecast. How were Nature's Sunshine Products' earnings last quarter? Nature's Sunshine Products, Inc. (NASDAQ:NATR) announced its quarterly earnings results on Tuesday, August, 7th. The company reported ($0.08) EPS for the quarter. The business had revenue of $91.27 million for the quarter. Nature's Sunshine Products had a trailing twelve-month return on equity of 12.25% and a net margin of 3.39%. What guidance has Nature's Sunshine Products issued on next quarter's earnings? Nature's Sunshine Products updated its FY 2024 earnings guidance on Tuesday, March, 12th. The company provided EPS guidance of for the period. The company issued revenue guidance of $455.0 million-$480.0 million, compared to the consensus revenue estimate of $464.3 million. What is Terrence Moorehead's approval rating as Nature's Sunshine Products' CEO? 13 employees have rated Nature's Sunshine Products Chief Executive Officer Terrence Moorehead on Glassdoor.com. Terrence Moorehead has an approval rating of 86% among the company's employees. What other stocks do shareholders of Nature's Sunshine Products own? Based on aggregate information from My MarketBeat watchlists, some companies that other Nature's Sunshine Products investors own include Amicus Therapeutics (FOLD), Gilead Sciences (GILD), Pfizer (PFE), AT&T (T), AbbVie (ABBV), Akorn (AKRX), Bausch Health Companies (BHC), Catalyst Pharmaceuticals (CPRX), Exelixis (EXEL) and Global Blood Therapeutics (GBT). Who are Nature's Sunshine Products' major shareholders? Nature's Sunshine Products' stock is owned by many different institutional and retail investors. Top institutional investors include Dimensional Fund Advisors LP (3.89%), Vanguard Group Inc. (3.44%), Vanguard Group Inc. (3.44%), Wasatch Advisors LP (2.25%), Hillsdale Investment Management Inc. (1.04%) and Boston Partners (0.91%). Insiders that own company stock include Bryant J Yates, Daniel C Norman, Nathan G Brower and Wynnefield Partners Small Cap. View institutional ownership trends. How do I buy shares of Nature's Sunshine Products? Shares of NATR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NATR) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nature's Sunshine Products, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.